In the
first issue of the year, there are new or updated reviews of:
- Selenium supplementation for the primary prevention of cardiovascular disease Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
- Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
- Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
- Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
- Slum upgrading strategies involving physical environment and infrastructure interventions and their effects on health and socio-economic outcomes